OVID Butterfly Strategy
OVID (Ovid Therapeutics Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule for treating epilepsies. It also develops OV882, a short hairpin RNA gene therapy for the treatment of angelman syndrome; and OV815 for the treatment of kinesin-family of proteins associated neurological disorder. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, and Northwestern University, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
OVID (Ovid Therapeutics Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $369.3M, a beta of 0.18 versus the broader market, a 52-week range of 0.27-3.105, average daily share volume of 3.2M, a public-listing history dating back to 2017, approximately 23 full-time employees. These structural characteristics shape how OVID stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.18 indicates OVID has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a butterfly on OVID?
A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration.
Current OVID snapshot
As of May 15, 2026, spot at $2.65, ATM IV 104.00%, IV rank 17.74%, expected move 29.82%. The butterfly on OVID below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this butterfly structure on OVID specifically: OVID IV at 104.00% is on the cheap side of its 1-year range, which favors premium-buying structures like a OVID butterfly, with a market-implied 1-standard-deviation move of approximately 29.82% (roughly $0.79 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated OVID expiries trade a higher absolute premium for lower per-day decay. Position sizing on OVID should anchor to the underlying notional of $2.65 per share and to the trader's directional view on OVID stock.
OVID butterfly setup
The OVID butterfly below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With OVID near $2.65, the first option leg uses a $2.52 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed OVID chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 OVID shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $2.52 | N/A |
| Sell 2 | Call | $2.65 | N/A |
| Buy 1 | Call | $2.78 | N/A |
OVID butterfly risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit.
OVID butterfly payoff curve
Modeled P&L at expiration across a range of underlying prices for the butterfly on OVID. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use butterfly on OVID
Butterflies on OVID are pinning bets - traders use them when they expect OVID to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
OVID thesis for this butterfly
The market-implied 1-standard-deviation range for OVID extends from approximately $1.86 on the downside to $3.44 on the upside. A OVID long call butterfly is a pinning play: it pays maximum at the middle strike if OVID settles there at expiration, with the wing legs capping both the cost and the maximum loss to the net debit. Current OVID IV rank near 17.74% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on OVID at 104.00%. As a Healthcare name, OVID options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to OVID-specific events.
OVID butterfly positions are structurally neutral / pin (limited-risk, limited-reward); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. OVID positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move OVID alongside the broader basket even when OVID-specific fundamentals are unchanged. Always rebuild the position from current OVID chain quotes before placing a trade.
Frequently asked questions
- What is a butterfly on OVID?
- A butterfly on OVID is the butterfly strategy applied to OVID (stock). The strategy is structurally neutral / pin (limited-risk, limited-reward): A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration. With OVID stock trading near $2.65, the strikes shown on this page are snapped to the nearest listed OVID chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are OVID butterfly max profit and max loss calculated?
- Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit. For the OVID butterfly priced from the end-of-day chain at a 30-day expiry (ATM IV 104.00%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a OVID butterfly?
- The breakeven for the OVID butterfly priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current OVID market-implied 1-standard-deviation expected move is approximately 29.82%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a butterfly on OVID?
- Butterflies on OVID are pinning bets - traders use them when they expect OVID to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
- How does current OVID implied volatility affect this butterfly?
- OVID ATM IV is at 104.00% with IV rank near 17.74%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.